Prestige BioPharma950210 
$10.05-1.89%24h
-1.89%24h
Global rank10370
Market cap$601.28M
Change 7d-7.54%
YTD Performance41.26%
SP500 benchmarkOutperform
P/E0.03
P/S4987.94
Revenue$120.55K
Earnings-$2.13M
Dividend yield-
Prestige BioPharma (950210) Total Liabilities
950210 Total Liabilities in 2022: $145.52M
According to Prestige BioPharma latest financial reports the total liabilities of 950210 is $145.52M, an increase of 179.58% to 2022. At the end of 2022 company had $52.05M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Prestige BioPharma is responsible for during its operational activities.
Prestige BioPharma (950210) Total Liabilities History from 2023 to 2022
-
Value:-
950210 Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $145.52M | 179.58% |
| 2022 | $52.05M | 139.26% |
| 2021 | $21.75M | 30.98% |
| 2020 | $16.61M | - |
View the Top Total Liabilies Stocks
